A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/14 (2006.01) A61K 31/02 (2006.01) A61K 31/025 (2006.01) A61K 38/42 (2006.01) A61K 47/06 (2006.01)
Patent
CA 2222066
A method for hemodiluting a patient is disclosed which includes the steps of administering a biocompatible oxygen carrier in conjunction with surgery or organ ischemia or infarct while assessing the patient's PvO2 or other oxygenation indices, and administering to the patient additional oxygen carrier or autologous blood in response to the PvO2 value if necessary to maintain the PvO2 at or above the desired level.
Méthode d'hémodilution chez un patient, consistant à administrer un transporteur d'oxygène biocompatible simultanément à un acte chirurgical ou une ischémie d'organe ou un infarctus, tout en mesurant la pression PvO¿2? du patient ou d'autres indices d'oxygénation, et à administrer au patient un transporteur d'oxygène supplémentaire, ou du sang autologue, si cela s'avère nécessaire suivant la valeur de PvO¿2? indiquée, pour maintenir le niveau de PvO¿2? au niveau désiré ou au-dessus.
Faithfull Nicholas Simon
Hopkins Ronald M.
Keipert Peter E.
Roth Duane J.
Alliance Pharmaceutical Corp.
Sim & Mcburney
LandOfFree
Hemodilution facilitated by monitoring oxygenation status does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemodilution facilitated by monitoring oxygenation status, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemodilution facilitated by monitoring oxygenation status will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1752381